[ARCHIVE] Neptune Technologies & Bioressources appoints Reed Tuckson to its Board as Independent Director
– CANADA, QC – Neptune Technologies & Bioressources Inc. (Nasdaq: NEPT | TSX: NTB) today announced the appointment of Dr.…
Biotechnology
Tauriga Sciences appoints Jason Heikenfeld to its Scientific Advisory Board
– USA, NY – Tauriga Sciences Inc. (OTCQB:TAUG), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nanorobotics space, has today announced the appointment of Jason C.…
Celladon appoints Michael Narachi as Chairman of the Board of Directors
– USA, CA – Celladon Corporation, a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced that it has appointed Michael Narachi as Chairman of the Board of Directors.…
OncoMed Pharmaceuticals appoints Mike Wyzga to Board of Directors
– USA, CA – OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced the appointment of independent director Michael Wyzga to the company’s Board of Directors.…
ValiRx appoints Seppo Mäkinen as Non-Executive Director and Oliver de Giorgio-Miller as Non-Executive Chairman
– UK, London – ValiRx Plc (AIM: VAL), a life science company with a focus on cancer diagnostics and personalised therapeutic development announces the following board changes:
- Appointment of Mr Seppo Olavi Mäkinen as a Non-Executive Director of the Company
Seppo Mäkinen has more than 25 years of senior advisory and executive experience in board level strategic leadership and venture capital management on life science.…
